Cancer medicines
Osimertinib
Osimertinib
A targeted medicine for lung cancers with certain EGFR mutations.
Sources checked · Introductory guide
On this page
How it works
An oral tyrosine kinase inhibitor acting on EGFR.[1]
Where it is used
Used in non-small cell lung cancer with specific EGFR mutations, depending on stage and prior treatment.[1]
Key safety points
Besides diarrhea and skin symptoms, lung or heart problems can occur. Report new breathlessness, cough or palpitations promptly.[2]
Questions for your care team
- Does my EGFR mutation qualify, and which other medicines need review?
Sources and scope
Source documents are in English.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.